Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

PMCB PharmaCyte Biotech Inc

2,1087

-0,0513 (-2,37%)

Zuletzt aktualisiert: 15:46:43

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more PharmaCyte Biotech Charts.

News PharmaCyte Biotech Inc

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 15 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 28 November 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 24 November 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Mittwoch 22 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Weitere PharmaCyte Biotech Inc News-Artikel

Euro vs Sterling

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Deutsche Telekom

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen